A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This research is being conducted to determine the biodistribution of radiolabeled amatuximab in tumor and non-tumor tissues in subjects with mesothelin over expressing cancer including mesothelioma, pancreatic, ovarian or non small cell lung cancer.
Epistemonikos ID: 3723432cd46abad5c188257b51b665e9354e255c
First added on: May 10, 2024